You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Silibinin

Showing 1 - 25 of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Metastases, Adult Trial in Rozzano (Silibinin)

Recruiting
  • Brain Metastases, Adult
  • Silibinin
  • Rozzano, Milano, Italy
    IRCCS Humanitas Research Hospital
Mar 20, 2023

Overweight and Obesity, Hypercholesterolemia, Hypertriglyceridemia Trial in Murcia (Silibinin A)

Active, not recruiting
  • Overweight and Obesity
  • +2 more
  • Silibinin A
  • Murcia, Spain
    Faculty of Nursing. Catholic University of Murcia
May 17, 2022

Brain Metastases, Adult, Non Small Cell Lung Cancer, Breast Cancer Trial in Messina, Rome, Turin (Silibinin, Placebo)

Recruiting
  • Brain Metastases, Adult
  • +2 more
  • Silibinin
  • Placebo
  • Messina, Italy
  • +4 more
Jan 9, 2023

Amatoxin Poisoning, Amanita Poisoning, Mushroom Poisoning Trial in Somerset, Morgantown (Silibinin)

Terminated
Has Results
  • Amatoxin Poisoning
  • +3 more
  • Silibinin
  • Somerset, New Jersey
  • +1 more
Mar 16, 2022

Smoking Trial in Minneapolis (Indole-3-Carbinol, Silibinin, Silibin)

Completed
  • Smoking
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Aug 10, 2021

Nonalcoholic Fatty Liver Disease Trial in Dongguan (Silibinin extract, mixed power of pueraria, schisandra and salvia

Recruiting
  • Nonalcoholic Fatty Liver Disease
  • Silibinin extract, mixed power of pueraria, schisandra and salvia miltiorrhiza
  • +2 more
  • Dongguan, Guangdong, China
    Department of Nutrition, School of Public Health, Guangdong Medi
Aug 9, 2022

Covid19, Liver Diseases Trial in Banska Bystrica, Bratislava (Silymarin)

Completed
  • Covid19
  • Liver Diseases
  • Banska Bystrica, Slovakia
  • +1 more
Aug 2, 2022

Atrial Fibrillation New Onset Trial in Sremska Kamenica (Silymarin)

Recruiting
  • Atrial Fibrillation New Onset
  • Sremska Kamenica, Serbia
    Institute of Cardiovascular Diseases of Vojvodina
Nov 3, 2023

Colon Cancer Trial in New York (Green Tea and Milk Thistle Supplements)

Unknown status
  • Colon Cancer
  • Green Tea and Milk Thistle Supplements
  • New York, New York
    Mount Sinai St. Luke's Roosevelt Hospital Center
Feb 22, 2021

Body Dysmorphic Disorder Trial in Chicago (Milk Thistle, Placebo)

Recruiting
  • Body Dysmorphic Disorder
  • Milk Thistle
  • Placebo
  • Chicago, Illinois
    University of Chicago
Mar 16, 2022

Melasma Trial (Silymarin, Microneedling)

Not yet recruiting
  • Melasma
  • Silymarin
  • Microneedling
  • (no location specified)
Oct 19, 2021

Fatty Liver Disease Trial in Guangzhou (Tablet of silybum marianum, Pueraria lobate and salvia miltiorrhiza, Placebo tablet)

Active, not recruiting
  • Fatty Liver Disease
  • Tablet of silybum marianum, Pueraria lobate and salvia miltiorrhiza
  • Placebo tablet
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
Sep 29, 2021

Drug-induced Liver Injury Trial in Frankfurt (Placebo, 2x 140 mg per day, 3x 280 mg per day)

Active, not recruiting
  • Drug-induced Liver Injury
  • Placebo
  • +3 more
  • Frankfurt, Hessia, Germany
  • +1 more
Nov 21, 2021

Hepatitis C Trial in Wien (Silibinin)

Completed
  • Hepatitis C
  • Silibinin
  • Wien, Austria
    Medical University of Vienna
Mar 22, 2017

Drug-induced Liver Injury in China(DILI-P)

Unknown status
  • Drug-induced Liver Injury
    • Shanghai, China
      Renji hospital
    Apr 26, 2020

    Superior Silybin Bioavailability in Healthy Volunteers

    Completed
    • Liver Diseases
    • Chronic Liver Disease
    • Sylimarin and Sylibin
    • (no location specified)
    Feb 14, 2018

    Type 2 Diabetes Trial in Palermo (Dapagliflozin 10mg, Metformin)

    Unknown status
    • Type 2 Diabetes Mellitus
    • Palermo, Italy
      University Hospital of Palermo
    Feb 22, 2018

    HIV, Hepatitis C Trial in Zurich (Intravenous Silibinin (iSIL))

    Completed
    • HIV
    • Hepatitis C
    • Intravenous Silibinin (iSIL)
    • Zurich, Switzerland
      Division of Infectious Diseases and Hospital Epidemiology, Unive
    Mar 4, 2015

    Hepatitis C, Chronic Trial in Cairo (Legalon® SIL (Silibinin), Pegylated interferon alfa2b, Ribavirin)

    Withdrawn
    • Hepatitis C, Chronic
    • Legalon® SIL (Silibinin)
    • +2 more
    • Cairo, Egypt
      Al-Manial University Hospital, Kasr El-Aini Faculty Medicine, Ca
    Mar 4, 2015

    Hepatitis C Virus Recurrence Trial in Bari (Silibinin (Legalon-SIL), Saline)

    Terminated
    • Hepatitis C Virus Recurrence
    • Bari, Italy
      Azienda Ospedaliero-Universitaria Policlinico Consorziale
    Mar 4, 2015

    Prostate Cancer Trial in Aurora (Silibin-Phytosome)

    Completed
    Has Results
    • Prostate Cancer
    • Aurora, Colorado
      University of Colorado Hospital
    Mar 3, 2014

    Advanced Hepatocellular Carcinoma Trial in New York (Silybin)

    Completed
    • Advanced Hepatocellular Carcinoma
    • New York, New York
      Columbia University Medical Center
    Nov 21, 2013

    Drug/Agent Toxicity by Tissue/Organ, Leukemia Trial in Canada, United States (silymarin)

    Completed
    • Drug/Agent Toxicity by Tissue/Organ
    • Leukemia
    • silymarin
    • Miami, Florida
    • +7 more
    Dec 17, 2013

    Atopic Asthma Trial in Nashville (Oral Silymarin, Oral Silymarin, maintenance dose, Placebo)

    Withdrawn
    • Atopic Asthma
    • Oral Silymarin
    • +2 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Feb 20, 2014

    HCV Recurrence After Liver Transplantation Trial (Silibinin, Placebo)

    Terminated
    • HCV Recurrence After Liver Transplantation
    • Silibinin
    • Placebo
    • (no location specified)
    Feb 14, 2012